WS Global Patient Registry
Events
Clinical Trials
Newsletters
Donate

WS Global Patient Registry
Wolfram Syndrome
The Foundation
Research
Events
- Art for Wolfram Syndrome
News
Resources
- How You Can Help
- Wolfram Articles
Contact
Donate
Search
Menu Menu

Social Media Posts

At-Home COVID Tests, Accessible for People Who Are Blind or Have Low Vision, Now Available

August 29, 2022:

At-Home COVID Tests, Accessible for People Who Are Blind or Have Low Vision, Now Available

Share this:

Click to share on Twitter (Opens in new window)
Click to share on Facebook (Opens in new window)
Click to share on Pinterest (Opens in new window)
Click to share on LinkedIn (Opens in new window)
Click to email a link to a friend (Opens in new window)

Like this:

Like Loading...

Related

August 29, 2022/by Bhushan Sreekrishnavilas

Share this entry

Share on Facebook
Share on Twitter
Share on WhatsApp
Share on Pinterest
Share on LinkedIn
Share on Tumblr
Share on Vk
Share on Reddit
Share by Mail

http://thesnowfoundation.org/wp-content/uploads/2019/06/snow-foundation_logo.svg 0 0 Bhushan Sreekrishnavilas http://thesnowfoundation.org/wp-content/uploads/2019/06/snow-foundation_logo.svg Bhushan Sreekrishnavilas2022-08-29 08:00:282022-07-20 22:05:21At-Home COVID Tests, Accessible for People Who Are Blind or Have Low Vision, Now Available

Categories

Adam Zwan
Dr. Fumihiko Urano
Dr. Tim Barrett
Events
Federica D'Elia
Global Research Updates
Lauren Gibilisco
Living With Wolfram Syndrome
Past Events
Podcasts
Research
Snow Foundation in the Media
Social Media Posts
Treatment
Wolfram Articles

Archives

Archives

About the Snow Foundation

The Snow Foundation is a collective voice for Wolfram syndrome patients, working towards a cure for Wolfram syndrome and developing novel therapies for diabetes, vision loss, hearing loss and neurodegeneration.

Rare Diseases…Common Problems

P.O. Box 50224 Clayton, MO 63105
(402) 694-1354

CONNECT WITH US

Facebook

Contact Us

Your Name:*
Your Email Address:*
Your Message:*

Δ

© Copyright - The Snow Foundation

Twitter
Facebook
Youtube
Instagram
Vimeo
Pinterest
Rss

Wolfram Syndrome Explained
About Us
Research
Media
Donate
Contact

AbbVie bets $370M on pivotal eye disease gene therapy, puts up $1.4B in biobucks...Biogen bails on AGTC after ocular gene therapy flunks trial | Fierce Biotec...

Loading Comments...

You must be logged in to post a comment.

%d